A Recovery-Oriented Perspective & Approach To Behavioral Health Care: A Discussion Among A Peer & A Clinical Provider On Goals & Aspirations For Individuals With A Mental Health Condition
From the Part II of the webinar on “A Recovery-Oriented Perspective and Approach to Behavioral Health Care”, hear from Alison A. Carroll, LCSW-R and Dwayne Mayes, MS share their professional and personal perspectives on goals and aspirations for individuals with a mental health condition.
Featuring:
- Alison A. Carroll, LCSW-R
- People USA Consultant and Former Senior Vice President of Business Development at The Mental Health Association of Westchester New York
- Dwayne Mayes, MS
- Program Director of the Recovery Network and Peer Training Program at The Mental Health Association of Westchester New York, PsychU Section Advisor for Patient and Caregivers
- Becky Wong, PharmD, MBA
Senior Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.
Alison A. Carroll, LCSW-R is semi-retired after over 35 years in the mental health field. She is currently consulting with People USA and was the former Senior Vice President of Business Development at The Mental Health Association of Westchester New York. She is a proud current member and past president of the New York Association of Psychiatric Rehabilitation Services (NYAPRS) Board. She has also served as board member of the New York State Care Management Coalition.
Dwayne Mayes, MS is the Advisor for PsychU’s Patient and Caregivers Section and a Program Director of the Recovery Network & Peer Training Program at the Mental Health Association of Westchester. He is also a former board member of the International Association of Peer Specialists.
Becky Wong, PharmD, MBA, is a Senior Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.
Alison A. Carroll, LCSW-R and Dwayne Mayes, MS are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Becky Wong, PharmD, MBA, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.
-
Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs Part 2
This part 2, on-demand webinar, examines the current PTSD treatment landscape, including discussions on both psychotherapy and pharmacotherapy. In addition, presenters review limitations and key considerations in the treatment of…